Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.

Saved in:
Bibliographic Details
Title: Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
Authors: Clark AS; University of Pennsylvania, Philadelphia, PA, USA. Amy.Clark@pennmedicine.upenn.edu., Yau C; University of California San Francisco, San Francisco, CA, USA., Wolf DM; University of California San Francisco, San Francisco, CA, USA., Petricoin EF; George Mason University, Fairfax, VA, USA., van 't Veer LJ; University of California San Francisco, San Francisco, CA, USA., Yee D; University of Minnesota, Minneapolis, MN, USA., Moulder SL; MD Anderson Cancer Center, Houston, TX, USA., Wallace AM; University of California San Diego, San Diego, CA, USA., Chien AJ; University of California San Francisco, San Francisco, CA, USA., Isaacs C; Georgetown University, Washington, DC, USA., Boughey JC; Mayo Clinic, Rochester, MN, USA., Albain KS; Loyola University, Chicago, IL, USA., Kemmer K; Oregon Health & Science University, Portland, OR, USA., Haley BB; University of Texas Southwestern, Dallas, TX, USA., Han HS; Moffitt Cancer Center, Tampa, FL, USA., Forero-Torres A; University of Alabama Birmingham, Birmingham, AL, USA., Elias A; University of Colorado Denver, Aurora, CO, USA., Lang JE; University of Southern California, Los Angeles, CA, USA., Ellis ED; Swedish Cancer Institute, Seattle, WA, USA., Yung R; University of Washington, Seattle, WA, USA., Tripathy D; MD Anderson Cancer Center, Houston, TX, USA., Nanda R; University of Chicago, Chicago, IL, USA., Wulfkuhle JD; MD Anderson Cancer Center, Houston, TX, USA., Brown-Swigart L; University of California San Francisco, San Francisco, CA, USA., Gallagher RI; MD Anderson Cancer Center, Houston, TX, USA., Helsten T; University of California San Diego, San Diego, CA, USA., Roesch E; University of California San Diego, San Diego, CA, USA., Ewing CA; University of California San Francisco, San Francisco, CA, USA., Alvarado M; University of California San Francisco, San Francisco, CA, USA., Crane EP; Georgetown University, Washington, DC, USA., Buxton M; Berry Consultants, LLC, Houston, TX, USA., Clennell JL; Berry Consultants, LLC, Houston, TX, USA., Paoloni M; Berry Consultants, LLC, Houston, TX, USA., Asare SM; University of California San Francisco, San Francisco, CA, USA., Wilson A; University of California San Francisco, San Francisco, CA, USA., Hirst GL; University of California San Francisco, San Francisco, CA, USA., Singhrao R; University of California San Francisco, San Francisco, CA, USA., Steeg K; University of California San Francisco, San Francisco, CA, USA., Asare A; University of California San Francisco, San Francisco, CA, USA., Matthews JB; University of California San Francisco, San Francisco, CA, USA., Berry S; Berry Consultants, LLC, Houston, TX, USA., Sanil A; Berry Consultants, LLC, Houston, TX, USA., Melisko M; University of California San Francisco, San Francisco, CA, USA., Perlmutter J; Gemini Group, Ann Arbor, MI, USA., Rugo HS; University of California San Francisco, San Francisco, CA, USA., Schwab RB; University of California San Diego, San Diego, CA, USA., Symmans WF; MD Anderson Cancer Center, Houston, TX, USA., Hylton NM; University of California San Francisco, San Francisco, CA, USA., Berry DA; Berry Consultants, LLC, Houston, TX, USA., Esserman LJ; University of California San Francisco, San Francisco, CA, USA., DeMichele AM; University of Pennsylvania, Philadelphia, PA, USA.
Source: Nature communications [Nat Commun] 2021 Nov 05; Vol. 12 (1), pp. 6428. Date of Electronic Publication: 2021 Nov 05.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Adaptive Clinical Trial
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34741023
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2<superscript>+</superscript> breast cancer in the adaptively randomized I-SPY2 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Clark+AS%22">Clark AS</searchLink>; University of Pennsylvania, Philadelphia, PA, USA. Amy.Clark@pennmedicine.upenn.edu.<br /><searchLink fieldCode="AU" term="%22Yau+C%22">Yau C</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wolf+DM%22">Wolf DM</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Petricoin+EF%22">Petricoin EF</searchLink>; George Mason University, Fairfax, VA, USA.<br /><searchLink fieldCode="AU" term="%22van+'t+Veer+LJ%22">van 't Veer LJ</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yee+D%22">Yee D</searchLink>; University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Moulder+SL%22">Moulder SL</searchLink>; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wallace+AM%22">Wallace AM</searchLink>; University of California San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chien+AJ%22">Chien AJ</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Isaacs+C%22">Isaacs C</searchLink>; Georgetown University, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Boughey+JC%22">Boughey JC</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Albain+KS%22">Albain KS</searchLink>; Loyola University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Kemmer+K%22">Kemmer K</searchLink>; Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Haley+BB%22">Haley BB</searchLink>; University of Texas Southwestern, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Han+HS%22">Han HS</searchLink>; Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Forero-Torres+A%22">Forero-Torres A</searchLink>; University of Alabama Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Elias+A%22">Elias A</searchLink>; University of Colorado Denver, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Lang+JE%22">Lang JE</searchLink>; University of Southern California, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ellis+ED%22">Ellis ED</searchLink>; Swedish Cancer Institute, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Yung+R%22">Yung R</searchLink>; University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Tripathy+D%22">Tripathy D</searchLink>; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Nanda+R%22">Nanda R</searchLink>; University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Wulfkuhle+JD%22">Wulfkuhle JD</searchLink>; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Brown-Swigart+L%22">Brown-Swigart L</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gallagher+RI%22">Gallagher RI</searchLink>; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Helsten+T%22">Helsten T</searchLink>; University of California San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Roesch+E%22">Roesch E</searchLink>; University of California San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ewing+CA%22">Ewing CA</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Alvarado+M%22">Alvarado M</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Crane+EP%22">Crane EP</searchLink>; Georgetown University, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Buxton+M%22">Buxton M</searchLink>; Berry Consultants, LLC, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Clennell+JL%22">Clennell JL</searchLink>; Berry Consultants, LLC, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Paoloni+M%22">Paoloni M</searchLink>; Berry Consultants, LLC, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Asare+SM%22">Asare SM</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wilson+A%22">Wilson A</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hirst+GL%22">Hirst GL</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Singhrao+R%22">Singhrao R</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Steeg+K%22">Steeg K</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Asare+A%22">Asare A</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Matthews+JB%22">Matthews JB</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Berry+S%22">Berry S</searchLink>; Berry Consultants, LLC, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Sanil+A%22">Sanil A</searchLink>; Berry Consultants, LLC, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Melisko+M%22">Melisko M</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Perlmutter+J%22">Perlmutter J</searchLink>; Gemini Group, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Schwab+RB%22">Schwab RB</searchLink>; University of California San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Symmans+WF%22">Symmans WF</searchLink>; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hylton+NM%22">Hylton NM</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Berry+DA%22">Berry DA</searchLink>; Berry Consultants, LLC, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Esserman+LJ%22">Esserman LJ</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22DeMichele+AM%22">DeMichele AM</searchLink>; University of Pennsylvania, Philadelphia, PA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2021 Nov 05; Vol. 12 (1), pp. 6428. <i>Date of Electronic Publication: </i>2021 Nov 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Adaptive Clinical Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34741023
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-021-26019-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6428
    Titles:
      – TitleFull: Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Clark AS
      – PersonEntity:
          Name:
            NameFull: Yau C
      – PersonEntity:
          Name:
            NameFull: Wolf DM
      – PersonEntity:
          Name:
            NameFull: Petricoin EF
      – PersonEntity:
          Name:
            NameFull: van 't Veer LJ
      – PersonEntity:
          Name:
            NameFull: Yee D
      – PersonEntity:
          Name:
            NameFull: Moulder SL
      – PersonEntity:
          Name:
            NameFull: Wallace AM
      – PersonEntity:
          Name:
            NameFull: Chien AJ
      – PersonEntity:
          Name:
            NameFull: Isaacs C
      – PersonEntity:
          Name:
            NameFull: Boughey JC
      – PersonEntity:
          Name:
            NameFull: Albain KS
      – PersonEntity:
          Name:
            NameFull: Kemmer K
      – PersonEntity:
          Name:
            NameFull: Haley BB
      – PersonEntity:
          Name:
            NameFull: Han HS
      – PersonEntity:
          Name:
            NameFull: Forero-Torres A
      – PersonEntity:
          Name:
            NameFull: Elias A
      – PersonEntity:
          Name:
            NameFull: Lang JE
      – PersonEntity:
          Name:
            NameFull: Ellis ED
      – PersonEntity:
          Name:
            NameFull: Yung R
      – PersonEntity:
          Name:
            NameFull: Tripathy D
      – PersonEntity:
          Name:
            NameFull: Nanda R
      – PersonEntity:
          Name:
            NameFull: Wulfkuhle JD
      – PersonEntity:
          Name:
            NameFull: Brown-Swigart L
      – PersonEntity:
          Name:
            NameFull: Gallagher RI
      – PersonEntity:
          Name:
            NameFull: Helsten T
      – PersonEntity:
          Name:
            NameFull: Roesch E
      – PersonEntity:
          Name:
            NameFull: Ewing CA
      – PersonEntity:
          Name:
            NameFull: Alvarado M
      – PersonEntity:
          Name:
            NameFull: Crane EP
      – PersonEntity:
          Name:
            NameFull: Buxton M
      – PersonEntity:
          Name:
            NameFull: Clennell JL
      – PersonEntity:
          Name:
            NameFull: Paoloni M
      – PersonEntity:
          Name:
            NameFull: Asare SM
      – PersonEntity:
          Name:
            NameFull: Wilson A
      – PersonEntity:
          Name:
            NameFull: Hirst GL
      – PersonEntity:
          Name:
            NameFull: Singhrao R
      – PersonEntity:
          Name:
            NameFull: Steeg K
      – PersonEntity:
          Name:
            NameFull: Asare A
      – PersonEntity:
          Name:
            NameFull: Matthews JB
      – PersonEntity:
          Name:
            NameFull: Berry S
      – PersonEntity:
          Name:
            NameFull: Sanil A
      – PersonEntity:
          Name:
            NameFull: Melisko M
      – PersonEntity:
          Name:
            NameFull: Perlmutter J
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Schwab RB
      – PersonEntity:
          Name:
            NameFull: Symmans WF
      – PersonEntity:
          Name:
            NameFull: Hylton NM
      – PersonEntity:
          Name:
            NameFull: Berry DA
      – PersonEntity:
          Name:
            NameFull: Esserman LJ
      – PersonEntity:
          Name:
            NameFull: DeMichele AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 11
              Text: 2021 Nov 05
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1